Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
AANA J ; 91(4): 23-27, 2023 Aug.
Article in English | MEDLINE | ID: mdl-38809192

ABSTRACT

The U.S. was at war for nearly two decades, supporting unprecedented survival on the battlefield. As the nation pivots to a relative peace, it is critical that U.S. Army certified registered nurse anesthetist (CRNA) leaders mitigate the loss of lessons learned and prepare future Army CRNAs for war. This article describes the U.S. Army CRNA Readiness Model that incorporates the knowledge, skills, and abilities required to sustain readiness. This model will provide U.S. Army nursing leaders with the framework to implement and evaluate solider readiness to provide anesthesia in operational environments.


Subject(s)
Military Nursing , Nurse Anesthetists , Nurse Anesthetists/standards , Humans , United States , Models, Nursing , Clinical Competence/standards
2.
AANA J ; 79(2): 109-14, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21560973

ABSTRACT

The purpose of this study was to investigate the anxiolytic effects of myristicin, a major compound found in nutmeg, and its potential interaction with the gamma-aminobutyric acid (GABA(A)) receptor in male Sprague-Dawley rats. Nutmeg has traditionally been used as a spice in food preparation and as an herbal remedy in the treatment of many medical conditions, including anxiety. Fifty-five rats were divided equally into 5 groups: control (vehicle); myristicin; midazolam (positive control); flumazenil and myristicin; and midazolam and myristicin. The behavioral component of anxiety was examined by using the elevated plus-maze (open-arm and closed-arm times) along with analysis of gross and fine motor movements. Data analysis was performed using a 2-tailed multivariate analysis of variance (MANOVA) and least significant difference post-hoc test. Our data suggest that myristicin does not decrease anxiety by modulation of the GABA(A) receptor but may promote anxiogenesis. When myristicin was combined with midazolam, an antagonist-like effect similar to the flumazenil and myristicin combination was exhibited by a decrease in anxiolysis compared with the midazolam-only group. Myristicin may antagonize the anxiolytic effects of midazolam, increase anxiety, and affect motor movements.


Subject(s)
Anti-Anxiety Agents/pharmacology , Anxiety/drug therapy , Benzyl Compounds/pharmacology , Dioxolanes/pharmacology , Maze Learning/drug effects , Myristica/chemistry , Pyrogallol/analogs & derivatives , Allylbenzene Derivatives , Animals , Drug Evaluation, Preclinical , Flumazenil/pharmacology , GABA Modulators/pharmacology , Male , Midazolam/pharmacology , Nurse Anesthetists , Pyrogallol/pharmacology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...